SCHEMBL896836

SCHEMBL896836

[O]C(=O)CF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11506016 0.73
Fluoroacetate SCHEMBL19809545 0.73 CASP1 (0.85)
Bicarbonate SCHEMBL20423487 0.73 CA1 (0.42)
SCHEMBL88444 0.70
SCHEMBL92092 0.70
Fluoroacetate SCHEMBL78188 0.70
Bicarbonate SCHEMBL28301336 0.70
Bicarbonate SCHEMBL6704540 0.70
Fluoroacetate SCHEMBL13651728 0.70
Fluoroacetate SCHEMBL5908770 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295343-A Perovskite solar cell with high electrical stability and preparation method thereof 中南大学 2023-12-26 CN claimed
CN-110225895-B Base protective film, adhesion preventing member, and method for forming adhesion preventing member 星和电机株式会社 2021-11-02 CN claimed
CN-108155409-B Barium-based dual-ion battery and preparation method thereof 深圳中科瑞能实业有限公司 2020-10-27 CN claimed
WO-2015097717-A2 AN IMPROVED PROCESS FOR THE PREPARATION OF β-CAROTENE LAURUS LABS PRIVATE LIMITED (IN) 2015-07-02 WO claimed
US-8754067-B2 22-haloacetoxy-homopregnacalciferol analogs and their uses WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2014-06-17 US claimed
US-8354530-B2 Preparation of HMG-CoA reductase inhibitors, in particular rosuvastatin calcium, introducing L-malic acid as source of chirality for side chain; statin core moiety is consecutively coupled with chiral segment containing 4 carbon atoms and segment containing 2 carbon atoms; treating hypercholesterolemia Lek Pharmaceuticals d. d (SI) 2013-01-15 US claimed
US-20120149669-A1 22-Haloacetoxy-Homopregnacalciferol Analogs and Their Uses WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2012-06-14 US claimed
WO-2012065050-A1 22-HALOACETOXY-HOMOPREGNACALCIFEROL ANALOGS AND THEIR USES WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2012-05-18 WO claimed
US-20080255170-A1 Process for the Synthesis of Rosuvastatin Calcium LEK PHARMACEUTICALS D.D (SI) 2008-10-16 US claimed
EP-1912953-A1 PROCESS FOR THE SYNTHESIS OF ROSUVASTATIN CALCIUM LEK Pharmaceuticals D.D. (SI) 2008-04-23 EP claimed
WO-2007017117-A1 PROCESS FOR THE SYNTHESIS OF ROSUVASTATIN CALCIUM LEK PHARMACEUTICALS D.D. (SI) 2007-02-15 WO claimed
US-20040116297-A1 Use of polyprenol and its derivatives for facilitating growth of plants KWON SEONG-RYONG (KR) 2004-06-17 US claimed
US-5437929-A Germanium phthalocyanine films EDISON POLYMER INNOVATION CORP. (US) 1995-08-01 US claimed
EP-0280240-B1 Cephalosporin derivatives, process for their preparation and antibacterial agents BANYU PHARMA CO LTD (JP) 1994-09-14 EP claimed
US-4943587-A INDOLE COMPOUNDS, TREATMENT OF ARTHRITIS, PAIN OR FEVER WARNER-LAMBERT COMPANY (US) 1990-07-24 US claimed
EP-0342682-A2 Hydroxamate derivatives of selected nonsteroidal anti-inflammatory acyl residues having cyclooxygenase and 5-lipoxygenase inhibition WARNER-LAMBERT COMPANY (US) 1989-11-23 EP claimed
CN-112280567-B Composition comprising compound functioning as dichromatic pigment 住友化学株式会社 2024-06-25 CN disclosed
EP-3957627-B1 6-MEMBERED HETEROCYCLIC DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME SHIONOGI & CO (JP) 2024-06-19 EP disclosed
EP-0054753-A1 Polyprenyl composition or compounds and process for the production thereof KURARAY CO., LTD. (JP) 1982-06-30 EP disclosed
US-4024131-A ANTIINFLAMMATORY PLURICHEMIE ANSTALT (FL) 1977-05-17 US disclosed